IRIS
LANZILLOTTA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.078
AS - Asia 2.297
NA - Nord America 2.208
SA - Sud America 487
Continente sconosciuto - Info sul continente non disponibili 133
AF - Africa 35
OC - Oceania 16
Totale 8.254
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.082
RU - Federazione Russa 1.473
CN - Cina 809
IT - Italia 789
SG - Singapore 765
BR - Brasile 379
SE - Svezia 249
HK - Hong Kong 245
VN - Vietnam 187
DE - Germania 123
FR - Francia 109
GB - Regno Unito 97
IN - India 59
CA - Canada 58
FI - Finlandia 51
BD - Bangladesh 48
AR - Argentina 40
MX - Messico 37
NL - Olanda 37
PL - Polonia 35
TR - Turchia 31
ES - Italia 28
JP - Giappone 28
AT - Austria 18
IQ - Iraq 18
CO - Colombia 17
ID - Indonesia 17
ZA - Sudafrica 15
EC - Ecuador 13
PH - Filippine 13
IE - Irlanda 12
PE - Perù 12
PK - Pakistan 12
UA - Ucraina 11
MY - Malesia 10
AU - Australia 9
IL - Israele 9
UZ - Uzbekistan 9
VE - Venezuela 8
JM - Giamaica 7
NZ - Nuova Zelanda 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
KE - Kenya 6
LT - Lituania 6
MD - Moldavia 6
RO - Romania 6
CR - Costa Rica 5
HU - Ungheria 5
MA - Marocco 5
PY - Paraguay 5
BE - Belgio 4
CH - Svizzera 4
EG - Egitto 4
GR - Grecia 4
GT - Guatemala 4
IR - Iran 4
LV - Lettonia 4
NI - Nicaragua 4
NP - Nepal 4
SA - Arabia Saudita 4
TN - Tunisia 4
UY - Uruguay 4
CZ - Repubblica Ceca 3
HN - Honduras 3
JO - Giordania 3
KR - Corea 3
AL - Albania 2
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
GY - Guiana 2
HR - Croazia 2
LB - Libano 2
PA - Panama 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BH - Bahrain 1
BO - Bolivia 1
CG - Congo 1
CY - Cipro 1
DM - Dominica 1
EU - Europa 1
KZ - Kazakistan 1
LK - Sri Lanka 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
Totale 8.122
Salva come PNG Salva come JPEG
Città #
Singapore 375
Dallas 307
Moscow 260
San Jose 256
Ashburn 247
Hong Kong 241
Shanghai 164
Beijing 156
Milan 126
New York 102
Council Bluffs 97
Hefei 85
Lauterbourg 81
Lawrence 69
Princeton 69
Los Angeles 67
Ho Chi Minh City 65
Rome 65
Santa Clara 50
Hanoi 46
Boardman 40
São Paulo 38
Helsinki 37
Munich 37
Phoenix 30
Warsaw 30
Orem 28
Denver 26
London 26
Nuremberg 26
Tokyo 23
Montreal 21
Poplar 19
Cagliari 17
Seattle 17
Atlanta 16
Florence 16
Naples 15
Pune 15
Ankara 14
Boston 14
Frankfurt am Main 14
Guangzhou 14
Turin 14
Bologna 13
Brooklyn 12
Chennai 12
Chicago 12
Dublin 12
Mexico City 12
Rio de Janeiro 12
Bari 10
Belo Horizonte 10
Pescara 10
Rovigo 10
Toronto 10
Verona 10
Amsterdam 9
Bergamo 9
Galliate 9
Houston 9
Kuala Lumpur 9
Stockholm 9
Baghdad 8
Johannesburg 8
Mumbai 8
Pietra Ligure 8
Querétaro 8
Secaucus 8
Tashkent 8
Turku 8
Vaprio d'Adda 8
Basingstoke 7
Breda 7
Falkenstein 7
Haiphong 7
Jakarta 7
Madrid 7
Mugnano di Napoli 7
New Delhi 7
Vienna 7
Belluno 6
Bogotá 6
Brasília 6
Cesano Boscone 6
City of London 6
Hangzhou 6
Jiaxing 6
Monza 6
Nairobi 6
Perugia 6
Quezon City 6
Quito 6
San Francisco 6
Auckland 5
Campo Grande 5
Caxias do Sul 5
Changsha 5
Hải Dương 5
Istanbul 5
Totale 3.917
Salva come PNG Salva come JPEG
Nome #
PACHIMENINGITE IPERTROFICA IGG4-CORRELATA: DIAGNOSI E RISPOSTA TERAPEUTICA 380
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 213
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 185
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 182
A subset of CD4+CD8α- Cytotoxic T cells is expanded in patients with IgG4-Related type 1 autoimmune pancreatitis and decreases with glucocorticoid treatment 177
IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients 166
ABS0671 IgG4-RELATED DISEASE IN OVERLAP WITH IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE: CLINICAL-PATHOLOGICAL CHARACTERISTICS AND THERAPEUTIC IMPLICATIONS OF AN ORPHAN DISEASE 156
A CD8α− Subset of CD4+SLAMF7+ Cytotoxic T Cells Is Expanded in Patients With IgG4-Related Disease and Decreases Following Glucocorticoid Treatment 148
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 138
Dupilumab as a potential steroid-sparing treatment for IgG4-related disease. 135
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: An open-label cohort study 132
A cd8 alpha-negative subset of cd4+slamf7+ cytotoxic t cells is expanded in patients with igg4-related disease and decreases following glucocorticoid treatment 132
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 132
Incidence of endocrine and exocrine insufficiency in patients with autoimmune pancreatitis at diagnosis and after treatment: a systematic review and meta-analysis 131
Association of autoimmune pancreatitis and intraductal papillary mucinous neoplasm. A retrospective analysis from a tertiary care referral center 126
Urgent manifestations of immunoglobulin G4-related disease 120
Igg4-related disease of the oral cavity. Case series from a large single-center cohort of italian patients 118
B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma 116
ASSOCIAZIONE TRA MALATTIA IGG4-CORRELATA E IMMUNOTERAPIA ALLERGENE-SPECIFICA. STUDIO EPIDEMIOLOGICO DI UN CENTRO DI RIFERIMENTO ITALIANO. 116
B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease. 114
La misurazione quantitativa dell’uptake di 18F-FDG in TC/PET riflette l’espansione dei plasmablasti circolanti nella malattia IgG4 correlata 113
Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase 112
Role of systemic immunosuppression on subglottic stenosis in granulomatosis with polyangiitis: Analysis of a single-centre cohort 111
Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes 111
Advances in the diagnosis and management of IgG4 related disease. 110
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study 109
Association of IgG4-related disease and systemic rheumatic disorders 107
Differential EUS findings in focal type 1 autoimmune pancreatitis and pancreatic cancer: A proof-of-concept study 107
Efficacy and safety of rituximab for IgG4-related pancreato-biliary disease: A systematic review and meta-analysis 105
Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation 104
Utility of the “2019 ACR/EULAR classification criteria” for the management of patients with IgG4-related disease 103
B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease 101
CLINICAL PHENOTYPES OF IGG4- RELATED DISEASE REFLECT DIFFERENCES IN EPIDEMIOLOGICAL FEATURES, SEROLOGICAL FINDINGS,AND PROGNOSTIC OUTCOMES 101
Antineutrophil cytoplasmic antibody positivity in IgG4-related disease: A case report and review of the literature. 99
A unique case of IgG4-related pachymeningitis treated with intrathecal rituximab 98
B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease 96
Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: A European multi-centre study 94
CIRCULATING PLASMABLASTS LEVELS REFLECT INFLAMMATORY ACTIVITY IN IGG4-RELATED DISEASE LESIONS AS ASSESSED BY QUANTITATIVE POSITRON EMISSION TOMOGRAPHY 93
Effects Of Glucocorticoids On B Cell Subpopulations In Patients With IgG4-Related type I autoimmune pancreatitis 92
CLINICAL MANIFESTATIONS OF IGG4-RELATED DISEASE ONSET REQUIRE ADMISSION TO THE EMERGENCY DEPARTMENT IN THE MAJORITY OF CASES. EXPERIENCE FROM A SINGLE ITALIAN REFERRAL CENTRE 90
B LYMPHOCYTES DIRECTLY CONTRIBUTE TO TISSUE FIBROSIS IN IGG4-RELATED DISEASE 89
EFFECTS OF GLUCOCORTICOIDS AND METHOTREXATE-BASED THERAPEUTIC REGIMENS ON B CELL SUBPOPULATIONS IN PATIENTS WITH IGG4-RELATED DISEASE 88
Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease 86
IDENTIFICAZIONE DI UNA SOTTOPOPOLAZIONE CD8- DI LINFOCITI CD4 CITOTOSSICI ESPANSA NEI PAZIENTI CON MALATTIA IGG4-CORRELATA E RESPONSIVA ALLA TERAPIA CON GLUCOCORTICOIDI 86
IMMUNOTERAPIA SPECIFICA E MALATTIA IgG4-CORRELATA: STUDIO EPIDEMIOLOGICO DI UN CENTRO DI RIFERIMENTO ITALIANO 86
INFLAMMATORY ACTIVITY OF IgG4-RELATED DISEASE LESIONS ASSESSED BY QUANTITATIVE POSITRON EMISSION TOMOGRAPHY CORRELATES WITH CIRCULATING PLASMABLASTS LEVELS 85
Deconstructing IgG4-related disease involvement of midline structures: Comparison to common mimickers. 82
An International, Multi-Specialty Validation Study of the IgG4-Related Disease Responder Index 82
Persistence of circulating T-follicular helper cells after rituximab is associated with relapse of IgG4-related disease 82
HLA-DRB1∗16 and -DQB1∗05 alleles are strongly associated with autoimmune pancreatitis in a cohort of hundred patients 82
CLINICAL PHENOTYPES OF IGG4-RELATED DISEASE REFLECT DIFFERENCES IN EPIDEMIOLOGICAL, IMMUNOLOGICAL AND PROGNOSTIC FEATURES 80
IGG4 RELATED HYPERTROPHIC PACHYMENINGITIS: DIAGNOSTIC APPROACH AND THERAPEUTIC OUTCOMES 78
Methotrexate as induction of remission therapy for localized manifestations of IgG4-Related Disease. 77
IgG4-RELATED DISEASE PRESENTATION REQUIRES ADMISSION TO THE EMERGENCY DEPARTMENT IN THE MAJORITY OF CASES 73
LONG-TERM EFFICACY OF RITUXIMAB MAINTENANCE THERAPY FOR IGG4- RELATED DISEASE RITUXIMAB MAINTENANCE THERAPY IN IGG4-RELATED DISEASE 72
METHOTREXATE AS INDUCTION OF REMISSION THERAPY FOR LOCALIZED MANIFESTATIONS OF IGG4-RELATED DISEASE 70
MALATTIA IGG4-CORRELATA: ESPERIENZA QUINQUENNALE MONOCENTRICA SU UNA CORTE ITALIANA DI 150 PAZIENTI (2013 - 2018) 70
INCREASE OF CIRCULATING MEMORY B CELLS AFTER GLUCOCORTICOID-INDUCED REMISSION PREDICTS IGG4-RELATED DISEASE RELAPSE 68
Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment 68
Intrathecal rituximab for IgG4-related hypertrophic pachymeningitis 67
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circula-ting plasmablasts in IgG4-related type 1 au-toimmune pancreatitis and other organs 65
EFFETTI DEL PREDNISONE SULLE SOTTOPOPOLAZIONI B LINFOCITARIE NEI PAZIENTI CON MALATTIA IgG4-CORRELATA 64
Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse 63
METHOTREXATE AS INDUCTION OF REMISSION THERAPY FOR LOCALIZED MANIFESTATIONS OF IGG4-RELATED DISEASE 63
Immunology of IgG4-related disease 62
EFFECTS OF COMBINED THERAPY WITH PREDNISONE AND METHOTREXATE ON B CELL SUBPOPULATIONS IN PATIENTS WITH IGG4-RELATED DISEASE 62
MERTK AND THE RESOLUTION OF INFLAMMATION IN IGG4-RELATED DISEASE 62
EFFECTS OF COMBINED THERAPY WITH PREDNISONE AND METHOTREXATE ON B CELL SUBPOPULATIONS IN PATIENTS WITH IGG4-RELATED DISEASE 62
The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease. 61
Mer tyrosine kinase as a possible link between resolution of inflammation and tissue fibrosis in IgG4-related disease 61
Disentangling inflammatory drivers of fibrosis in IgG4-related disease 60
IGG4 RELATED HYPERTROPHIC PACHYMENINGITIS: DIAGNOSTIC APPROACH AND THERAPEUTIC OUTCOMES 60
Methotrexate as induction of remission the-rapy for IgG4-Related type 1 Autoimmune Pancreatitis 57
DECONSTRUCTING LA MALATTIA DA IGG4 CON INTERESSAMENTO DELLE STRUTTURE MEDIANE: CONFRONTO CON I COMUNI “MIMICKERS” 55
The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease. 55
IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19 54
FENOTIPI CLINICI DELLA MALATTIA IGG4 CORRELATA: ANALISI CROSS-SECTIONAL DI UNA CORTE INTERNAZIONALE 53
Roles of Plasmablasts and B Cells in IgG4-Related Disease: Implications for Therapy and Early Treatment Outcomes 53
Serum IgG4 elevation in hyper-inflamed COVID-19 patients. Author's reply 51
Effects of glucocorticoids on B-cell subpopulations in patients with IgG4-related disease 51
EFFETTI DELLA TERAPIA CON PREDNISONE E METHOTREXATE SULLE SOTTOPOPOLAZIONI B LINFOCITARIE NEI PAZIENTI AFFETTI DA MALATTIA-IgG4 CORRELATA 51
EFFICACY AND SAFETY OF RITUXIMAB FOR INDUCTION OF REMISSION AND MAINTENANCE OF IGG4-RELATED DISEASE: EXPERIENCE FROM AN ITALIAN NATIONAL REFERRAL CENTRE 50
Serum IgG4 level predicts COVID-19 related mortality 49
IGG4-RELATED DISEASE IN ITALY: RESULTS FROM A MONOCENTRIC COHORT OF 150 PATIENTS (2013–2018) 49
Methotrexate as Induction of Remission Therapy for Type 1 Autoimmune Pancreatitis 48
EFFICACIA E SICUREZZA DELLA SOMMINISTRAZIONE INTRATECALE DI RITUXIMAB PER IgG4-RELATED PACHIMENINGITE IPERTROFICA REFRATTARIA 45
Maintenance Treatment for Type 1 Autoimmune Pancreatitis: Effectiveness and Development of the PrescrAIP Relapse Prediction Model 23
Chronic Rhinosinusitis With Nasal Polyposis in EGPA: A Real-Life Multidimensional Analysis Through Mepolizumab Dosing and Role of Adjunctive Endoscopic Sinus Surgery (ESS) 14
B-cell depletion with obinutuzumab for the treatment of IgG4-related disease 7
Totale 8.254
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.641
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.641
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022156 0 0 46 12 2 10 7 9 21 15 18 16
2022/2023546 170 93 42 6 12 54 53 40 33 5 12 26
2023/2024593 26 39 69 46 38 88 22 69 6 24 61 105
2024/20251.474 139 57 51 50 72 105 243 172 252 89 96 148
2025/20265.045 332 372 361 552 429 191 408 375 1.312 332 203 178
2026/2027406 117 232 57 0 0 0 0 0 0 0 0 0
Totale 8.254